Treatment of chronic post nasal drip leading to chronic cough with Indian brand name in detail
Reading File
Finding Sources
Finding Sources
Searching the Web
treatment chronic post nasal drip cough Indian brand names medicines 2024
Reading File
Reading Web Page
https://bioresscientia.com/article/managing-postnasal-drip-c…
Finding Sources
Reading File
Searching the Web
Indian brand names intranasal corticosteroids antihistamines montelukast decongestants post nasal drip India pharmacy
I now have comprehensive information. Let me compile the detailed answer.
Treatment of Chronic Post-Nasal Drip (PND) Leading to Chronic Cough - with Indian Brand Names
Understanding the Condition
Post-nasal drip (PND), now more accurately termed Upper Airway Cough Syndrome (UACS), is one of the three most common causes of chronic cough (alongside asthma and GERD). It results from excessive or altered nasal/sinus secretions draining down the pharynx, triggering the cough reflex. Chronic cough is defined as cough lasting more than 8 weeks.
Characteristics:
- Sensation of mucus dripping at the back of the throat
- Frequent throat-clearing
- Nasal quality to voice
- Cobblestoning of the posterior pharyngeal wall on examination
- CT sinuses may show mucosal thickening or opacification
Common underlying causes in India: Allergic rhinitis, chronic rhinosinusitis, vasomotor rhinitis, non-allergic (perennial) rhinitis, deviated nasal septum, and GERD coexisting with PND.
Step-by-Step Treatment Approach
Step 1: Identify and Treat the Cause
Treatment must target the underlying etiology of the PND:
| Cause | Treatment Priority |
|---|---|
| Allergic rhinitis | Intranasal corticosteroids + Antihistamines |
| Vasomotor rhinitis | Ipratropium nasal spray + Saline irrigation |
| Chronic rhinosinusitis | INCS + Saline rinse ± Antibiotics |
| Bacterial sinusitis | Antibiotics + INCS |
| GERD-triggered | PPI + Dietary modification |
Drug Categories with Indian Brand Names
1. Intranasal Corticosteroids (INCS) - FIRST-LINE TREATMENT
The cornerstone of therapy. Most effective for allergic-rhinitis-driven PND with chronic cough. Used preferably with the head-down position for optimal topical delivery. - Murray & Nadel's Textbook of Respiratory Medicine
| Generic Drug | Indian Brand Names | Dose |
|---|---|---|
| Fluticasone Propionate | Flomist, Nasoflo, Nasocort-F, Flixonase | 2 sprays/nostril once daily |
| Mometasone Furoate | Nasonex, Momeflo, Rhinase-M, Momate Nasal | 2 sprays/nostril once daily |
| Budesonide | Budecort Nasal, Rhinocort, Bud-Nasal | 2 sprays/nostril once-twice daily |
| Beclomethasone Dipropionate | Beconase, Beclate Nasal, Nasonex-B | 2 sprays/nostril twice daily |
| Triamcinolone Acetonide | Nasacort, Tri-Nasal | 2 sprays/nostril once daily |
| Ciclesonide | Omnaris Nasal | 2 sprays/nostril once daily |
Tip: Fluticasone (Flomist) and Mometasone (Nasonex/Momeflo) are the most widely prescribed in Indian clinical practice. Effects take 1-2 weeks to be fully appreciated; advise patients accordingly.
2. Antihistamines - Combined with INCS for Best Results
First-generation (preferred for UACS - anticholinergic drying effect helps reduce secretions):
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Chlorpheniramine Maleate (CPM) | Piriton, Cadistin, Allercet, Histacadine | 4 mg TDS orally |
| Hydroxyzine | Atarax, Hxz, Hydroxyzine IKON | 25 mg OD-BD |
| Promethazine | Phenergan, Fenactil | 25 mg at bedtime |
Second-generation (non-sedating; preferred for daytime use/allergic rhinitis):
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Cetirizine | Cetrizet, Zyrtec, Incid-L, Alerid | 10 mg OD |
| Levocetirizine | L-Cet, Vozet, Levocet, Xyzal | 5 mg OD at night |
| Fexofenadine | Allegra, Fexo, Fexigra, Telfast | 120-180 mg OD |
| Loratadine | Lorfast, Loratrol, Claritin | 10 mg OD |
| Desloratadine | Deslor, Lorday-D, Aerius | 5 mg OD |
| Bilastine | Bilaxa, Bilaz, Blisone | 20 mg OD |
| Rupatadine | Rupanex, Rupall, Rupali | 10 mg OD |
In India, fixed-dose combinations (FDCs) like Montelukast 10 mg + Fexofenadine 120 mg (brands: Montair-FX, Defcort-FX, Levolin-FX) are widely used for allergic rhinitis with cough.
3. Intranasal Antihistamine Sprays
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Azelastine Nasal | Astelin Nasal, Rhinolast | 1-2 sprays/nostril BD |
| Olopatadine Nasal | Olonas, Patanase | 2 sprays/nostril BD |
Combined INCS + Intranasal Antihistamine preparations (e.g., MP-AZE = Mometasone + Azelastine; brand Dymista locally available) offer superior relief over either alone.
4. Oral Decongestants
Used for short-term relief (max 5-7 days); caution in hypertensives, elderly:
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Pseudoephedrine | Sudafed, Decongest (often as combination) | 60 mg TDS |
| Phenylephrine | In combinations - Coscopin, Recofast, Sinarest | As per combination |
Combination examples available in India:
- Sinarest Tablet (Paracetamol + Chlorpheniramine + Phenylephrine + Caffeine)
- Recofast Plus (Paracetamol + Phenylephrine + Triprolidine)
- Nasivion (Oxymetazoline nasal drops - topical decongestant, max 3-5 days only)
- Otrivin (Xylometazoline nasal spray - topical, short-term only)
5. Ipratropium Bromide Nasal Spray (Anticholinergic)
Particularly effective for vasomotor rhinitis and excessive watery secretions. Dries up mucus without systemic side effects.
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Ipratropium 0.03% Nasal Spray | Ipravent Nasal, Atrovent Nasal, Duolin Nasal | 2 sprays/nostril BD-TDS |
6. Leukotriene Receptor Antagonists (LTRA)
Useful when allergic rhinitis is the driver, especially with coexisting asthma:
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Montelukast | Montair, Singulair, Montemac, Montek | 10 mg OD at bedtime |
FDC combinations in India:
- Montelukast + Levocetirizine: Montair LC, Levocet-M, Okacet-M
- Montelukast + Fexofenadine: Montair-FX, Allercet-M
- Montelukast + Desloratadine: Deslor-M, Aerius Plus
7. Mucolytics and Expectorants
Help thin and mobilize secretions, reducing the drip load:
| Generic | Indian Brand Names | Dose |
|---|---|---|
| Guaifenesin | Grilinctus, Mucinex, Guaifenesin Syrup | 200-400 mg Q4-6h |
| Ambroxol | Mucosolvan, Ambrolite-S, Alex-P syrup | 30 mg TDS |
| Bromhexine | Bispol, Bromex, Bisolvon | 8-16 mg TDS |
| N-Acetylcysteine (NAC) | Mucomix, NAC 600, Flumucil | 600 mg OD-BD (effervescent) |
| Carbocisteine | Mucodyne, Carbolex | 750 mg TDS |
8. Saline Nasal Irrigation
One of the most underutilized yet highly effective treatments in India:
| Product | Brand Names in India |
|---|---|
| Isotonic saline nasal rinse | Nasoclear, Tonimer, AquaMaris, Neilmed Sinus Rinse |
| Hypertonic saline spray | Otrivin Breathe Clean, Nasivion Saline |
Mechanism: Mechanically clears mucus and allergens, reduces mucosal edema, improves ciliary function. Use 2-4 times daily with Neti-pot or squeeze bottle.
9. Antibiotics (for Bacterial Rhinosinusitis)
Used only when mucopurulent discharge persists for >10 days with sinusitis features:
| Drug | Indian Brands | Duration |
|---|---|---|
| Amoxicillin-Clavulanate | Augmentin, Moxclav, Clavam | 10-14 days |
| Azithromycin | Zithromax, Azithral, Atm | 5 days |
| Levofloxacin | Levaquin, Levoflox, Tavanic | 5-7 days |
| Doxycycline | Doxt, Biodoxi, Lymecycline | 7-10 days |
10. Treatment of Coexisting GERD (if present)
GERD frequently coexists with PND and worsens chronic cough:
| Drug | Indian Brands |
|---|---|
| Pantoprazole | Pan 40, Pantop, Pantocid |
| Omeprazole | Omez, Prilosec, Omepure |
| Rabeprazole | Razo, Rablet, Nexpro |
| Esomeprazole | Nexium, Esomac, Nexpro-L |
11. Antitussives (for cough suppression - adjunct)
When cough is distressing despite treating the underlying cause:
| Drug | Indian Brands | Notes |
|---|---|---|
| Dextromethorphan (DXM) | Alex, Coscopin, DXM, Koflet-H | OTC; non-narcotic |
| Codeine (phosphate) | Codituss, schedule H | Last resort; opioid; avoid long-term |
| Levodropropizine | Levolin Cough, Levopront | Peripheral antitussive; good profile |
| Gabapentin | Gabapin, Neurontin, Gabatop | 300 mg/day for refractory/syncope-causing cough |
Treatment Algorithm Summary
Chronic PND with Cough
|
├─ Allergic Rhinitis
│ └─ INCS (Flomist/Nasonex) + 2nd-gen AH (L-Cet/Allegra)
│ ± Montelukast (Montair) + Saline rinse
│
├─ Vasomotor / Non-allergic Rhinitis
│ └─ Ipravent Nasal + INCS + Saline irrigation
│
├─ Bacterial Sinusitis
│ └─ Antibiotics (Augmentin) + INCS + Saline rinse
│
├─ GERD component
│ └─ PPI (Pan 40 / Razo) + dietary changes
│
└─ Refractory / Idiopathic Cough
└─ Gabapentin 300 mg/day OR Codeine (last resort)
Non-Pharmacological Measures (Important in Indian Context)
- Steam inhalation with Vicks VapoRub (menthol 2.6%) - most widely used home remedy in India; effective via cold receptor stimulation in the throat
- Adequate hydration - keeps mucus thin and easier to clear
- Elevation of head while sleeping (30-degree incline)
- Avoid triggers: Dust, smoke, cold air, strong odors, known allergens
- Humidifier in dry winter months (especially North India)
- Dietary: Avoid cold drinks, dairy (may thicken mucus in some), spicy foods if GERD present
- Nasal irrigation with saline (Nasoclear/Neilmed) 2-4x/day
When to Refer
- Cough persisting >8 weeks despite adequate treatment
- Unilateral symptoms (rule out neoplasm)
- Associated stridor, hemoptysis, weight loss
- Suspected structural abnormality (deviated septum, nasal polyps)
- CT scan/nasal endoscopy required
Key Takeaways
- INCS is the single most effective treatment - start with Flomist or Nasonex spray for 4-6 weeks minimum
- Combine INCS + antihistamine for maximal benefit (e.g., Nasonex + L-Cet)
- Saline irrigation (Nasoclear) is underused but highly effective - recommend to all patients
- Short-term decongestants (Otrivin, Nasivion) only; do NOT continue beyond 5 days to avoid rhinitis medicamentosa
- Treat GERD if suspected - often coexists and perpetuates cough
- India-specific FDCs like Montair LC, Montair-FX are convenient and widely available
- Gabapentin is an emerging option for refractory cough with syncope (per case reports from Indian practice)
Sources: Murray & Nadel's Textbook of Respiratory Medicine; Expert Panel Consensus Recommendations for Allergic Rhinitis in India (Pulmonary Therapy, Springer 2024); Managing Postnasal Drip Cough - Indian clinical perspective
Is there any role of im triamcinolone in above pt
Finding Sources
Finding Sources
Searching PubMed
intramuscular triamcinolone allergic rhinitis
Searching the Web
intramuscular triamcinolone acetonide allergic rhinitis post nasal drip evidence guidelines India
Reading File
Reading Article
PMID: 32051146
Reading Web Page
https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergi…
Excellent - I now have very clear authoritative data from Cummings Otolaryngology, AAAAI Rhinitis 2020 guidelines, and PubMed. Here is the complete answer:
Role of IM Triamcinolone in Chronic Post-Nasal Drip / UACS
Short Answer
Yes, but very limited, and largely discouraged by current guidelines. IM triamcinolone (depot steroid) has a narrow, specific role in severe/intractable cases only - and even then, most guidelines now recommend against its routine use due to a significant risk profile compared to safer alternatives.
What the Evidence and Guidelines Say
1. Cummings Otolaryngology (Authoritative ENT Textbook)
"Intramuscular injections of depo-steroids should NOT be used for the treatment of seasonal allergic rhinitis, except in extenuating circumstances, because a potential for decreased resistance to infection is always present during the 4-6 weeks after the injection. Furthermore, depo-steroid injections have long-term effects on bone density, cause systemic suppression of the hypothalamic-pituitary axis and have other systemic effects."
Oral/systemic steroids are reserved only for patients who present with total nasal obstruction mid-season where:
- Topical INCS cannot be delivered (due to complete blockage)
- Oral decongestants + antihistamines have failed
- A short-course oral steroid is still preferred over IM depot
2. AAAAI Rhinitis 2020 Practice Parameter Update (Most Current Major Guideline)
Recommendation 10 (CBS):
"We suggest that for the treatment of very severe or intractable AR, the clinician NOT prescribe a depot parenteral corticosteroid for AR due to the potential risks of systemic and local corticosteroid side effects."
- Strength: Conditional | Certainty of evidence: Very low
Why they say this: A 2013 Danish study (Aasbjerg et al., Respir Med 2013) showed that treating allergic rhinitis with depot-steroid injections increases the risk of osteoporosis and diabetes - a significant finding for a non-life-threatening condition.
3. Drug & Therapeutics Bulletin (2020 PubMed Review, PMID: 32051146)
Titled "Still no place for depot triamcinolone in hay fever?" - this review reaffirms that despite its widespread use in some countries (including India), depot triamcinolone for allergic rhinitis/hay fever has no established place in evidence-based management.
Why IM Triamcinolone Is Still Widely Used in India (Clinical Reality)
Despite the guideline caution, IM Triamcinolone (Tricort 40, Kenalog 40, Kenacort 40 mg/mL) is commonly administered in Indian clinical practice for the following practical reasons:
| Reason | Reality |
|---|---|
| Poor patient compliance with daily nasal sprays | A single injection "guarantees" 3-4 weeks of effect |
| Cost concerns | Cheaper than a month of branded INCS |
| Rapid, dramatic symptom relief | Useful for patients who need immediate relief |
| Patient demand / expectation | Common in tier-2/tier-3 cities |
Indian brands available:
- Tricort 40 (Cadila) - Triamcinolone Acetonide 40 mg/mL
- Kenacort 40 (Sanofi) - Triamcinolone Acetonide 40 mg/mL
- Kenalog 40 (Squibb/BMS)
- Triam-Forte (Pfizer)
Typical dose used: 40 mg IM deep gluteal - single injection, may repeat after 4-6 weeks if needed.
Specific Risks to Discuss with the Patient
| Risk | Significance |
|---|---|
| HPA axis suppression | Even a single 40 mg dose can suppress the axis for 4-6 weeks |
| Hyperglycemia | Significant; caution in diabetics and pre-diabetics |
| Osteoporosis | Risk with repeated injections |
| Subcutaneous/local atrophy | If injection is not deep IM |
| Immunosuppression | Increased infection risk for 4-6 weeks post-injection |
| Adrenal insufficiency | With repeated injections or abrupt stop |
| Avascular necrosis | Rare but reported with repeated depot steroids |
| Cushingoid features | With frequent use |
When IM Triamcinolone May Be Considered (Narrow Indications)
Given all the above, it may be acceptable only in these specific scenarios:
- Total nasal obstruction preventing delivery of topical INCS - as a one-time bridge to open the airway, followed by INCS
- Non-compliant patient who refuses/cannot use daily nasal sprays and has severe symptoms significantly affecting quality of life
- Pre-exposure prophylaxis in known severe seasonal allergy (e.g., teacher who needs to function during peak pollen season with no option for alternatives)
- Intractable cough syncope from PND - where rapid symptom control is urgently needed
Even in these cases, a short oral steroid course (Prednisolone 20-30 mg/day x 5-7 days) is the preferred alternative - it achieves similar effect with a shorter, more controllable duration of systemic exposure.
Summary: IM Triamcinolone vs. Safer Alternatives
| Feature | IM Triamcinolone | Oral Prednisolone (short course) | INCS (Flomist/Nasonex) |
|---|---|---|---|
| Efficacy | High | High | High |
| Speed of onset | 24-48 hrs | 24-48 hrs | 3-7 days |
| Duration | 3-6 weeks (uncontrollable) | 5-7 days (controllable) | Ongoing (controlled) |
| HPA suppression | Yes, prolonged | Minimal with short course | Negligible |
| Systemic side effects | Significant | Minimal | Negligible |
| Guideline recommendation | Against (AAAAI 2020) | Conditional (for severe) | First-line |
| Indian practice | Widely used (off-guideline) | Used | Underused |
Bottom Line
IM Triamcinolone has no routine role in chronic PND/UACS. It is an off-guideline practice that carries real systemic risks for a condition that responds well to safe topical therapy. If a bridge steroid is genuinely needed, a short-course oral prednisolone is preferred. The goal should always be to establish the patient on INCS + antihistamine + saline rinse as the definitive long-term regimen.
Sources: Cummings Otolaryngology (p. 718); AAAAI Rhinitis 2020 Practice Parameter Update - Recommendation 10; Drug Ther Bull 2020 PMID:32051146
This is a shared conversation. Sign in to Orris to start your own chat.